These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19414295)

  • 21. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
    El Hallani S; Ducray F; Idbaih A; Marie Y; Boisselier B; Colin C; Laigle-Donadey F; Rodéro M; Chinot O; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2009 Jan; 72(4):332-6. PubMed ID: 19171829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
    Birch JM; Alston RD; McNally RJ; Evans DG; Kelsey AM; Harris M; Eden OB; Varley JM
    Oncogene; 2001 Aug; 20(34):4621-8. PubMed ID: 11498785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identification of a novel TP53 germline mutation in one child with adrenocortical carcinoma].
    Si N; Sun M; Lu CX; Liu YS; Qi Z; Yang W; Zhao XL; Zhang X
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1402-4. PubMed ID: 19671334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
    Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.
    Bumroongkit K; Rannala B; Traisathit P; Srikummool M; Wongchai Y; Kangwanpong D
    Cancer Genet Cytogenet; 2008 Aug; 185(1):20-7. PubMed ID: 18656689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
    Fiszer-Maliszewska L; Czernik J; Sawicz-Birkowska K; Perek D; Kozera M; Wojciechowska B; Kazanowska B; Hudziec P; Kilar E
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):309-15. PubMed ID: 11059649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
    Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germ-line genetic variation of TP53 in osteosarcoma.
    Savage SA; Burdett L; Troisi R; Douglass C; Hoover RN; Chanock SJ;
    Pediatr Blood Cancer; 2007 Jul; 49(1):28-33. PubMed ID: 17096406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
    Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
    J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.
    Wang-Gohrke S; Weikel W; Risch H; Vesprini D; Abrahamson J; Lerman C; Godwin A; Moslehi R; Olipade O; Brunet JS; Stickeler E; Kieback DG; Kreienberg R; Weber B; Narod SA; Runnebaum IB
    Br J Cancer; 1999 Sep; 81(1):179-83. PubMed ID: 10487631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
    Tabori U; Nanda S; Druker H; Lees J; Malkin D
    Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
    Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
    Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.